BMJ · 2021 · 12 citations · 17 references
MedicineClinical SciencesInfectious Disease ControlPulmonary Function TestingPulmonologySelf-management SupportContinuous Positive Airway PressureDisease ControlRespiratory DiseaseRespiratory Infection ControlRespiratory MedicineSelf-managementCovid-19-associated Acute Respiratory Distress SyndromeOscillatory Positive Expiratory PressureOutcome MeasuresPositive End-expiratory Pressure EffectsRespiratory Complication PreventionSars-cov-2 InfectionSars-cov-2 Pneumonia
OBJECTIVE: To determine whether positive expiratory pressure (PEP) by PEP flute self-care is effective in reducing respiratory symptoms among community dwelling adults with SARS-CoV-2 infection and early stage covid-19. DESIGN: Non-drug, open label, randomised controlled trial. SETTING: Capital Region and Region Zealand in Denmark from 6 October 2020 to 26 February 2021. PARTICIPANTS: Community dwelling adults, able to perform self-care, with a new SARS-CoV-2 infection (verified by reverse transcription polymerase chain reaction tests) and symptoms of covid-19. INTERVENTION: Participants were randomised to use PEP flute self-care in addition to usual care or have usual care only. Randomisation was based on permuted random blocks in a 1:1 ratio, stratified for sex and age (<60 or ≥60 years). The PEP self-care group was instructed to use a PEP flute three times per day during the 30 day intervention. MAIN OUTCOME MEASURES: Primary outcome was a change in symptom severity from baseline to day 30, as assessed by the self-reported COPD (chronic obstructive pulmonary disease) assessment test (CAT), which was adjusted for baseline values and stratification factors. Participants completed the CAT test questionnaire every day online. Secondary outcomes were self-reported urgent care visits due to covid-19, number of covid-19 related symptoms, and change in self-rated health, all within 30-days' follow-up. RESULTS: 378 participants were assigned to the PEP flute self-care intervention (n=190) or usual care only (n=188). In the PEP self-care group, the median number of days with PEP flute use was 21 days (interquartile range 13-25). For the intention-to-treat population, a group difference was observed in changes from baseline in CAT scores of -1.2 points (95% confidence interval -2.1 to -0.2; P=0.017) in favour of the PEP flute self-care group. At day 30, the PEP flute self-care group also reported less chest tightness, less dyspnoea, more vigour, and higher level of daily activities, but these differences were small, and no consistent effects were seen on the secondary outcomes. No serious adverse events were reported. CONCLUSIONS: In community dwelling adults with early covid-19, PEP flute self-care had a significant, yet marginal and uncertain clinical effect on respiratory symptom severity, as measured by CAT scores. TRIAL REGISTRATION: ClinicalTrials.gov NCT04530435.
17
Paul A. Harris, Robert Taylor, Robert J. Thielke et al. · Journal of Biomedical Informatics · 2008 · 51.7K citations · Full text
Annemarie B Docherty, Ewen M. Harrison, Christopher Green et al. · BMJ · 2020 · 3.6K citations · Full text
Veterinary Medicine, Infectious Diseases, Internal Medicine +13
Development and first validation of the COPD Assessment Test
Paul Jones, Gale Harding, Pamela Berry et al. · European Respiratory Journal · 2009 · 3.2K citations · Full text
Attributes and predictors of long COVID
Carole H. Sudre, Benjamin Murray, Thomas Varsavsky et al. · Nature Medicine · 2021 · 2.6K citations · Full text
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19
Eric J. Lenze, Caline Mattar, Charles F. Zorumski et al. · JAMA · 2020 · 517 citations · Full text